Pizzuti Dana bought CRNX

January 3, 2024 · Form 4 insider transaction

Pizzuti Dana bought 14,375 shares of Crinetics Pharmaceuticals, Inc. at $16.89 per share, a transaction worth $242.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.